2001
DOI: 10.1006/bioo.2001.1227
|View full text |Cite
|
Sign up to set email alerts
|

Synthesis of RGD Analogs as Potential Vectors for Targeted Drug Delivery

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
7
0

Year Published

2005
2005
2023
2023

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 12 publications
(7 citation statements)
references
References 32 publications
0
7
0
Order By: Relevance
“…The enhancement of PCL-NGF scaffolds of on the growth of PC12 cells in this study could be due to the interactions of NGF and Trk A receptors on the membrane of PC12 cells [16e18]. Furthermore, the rate of cellular uptake of RGD-modified polymeric micelles by PC12 cells was enhanced compared to that of micelles without modification [12,13]. Since TF has the same functions as RGD integrin, the promotion by TF on the growth of PC12 cells in PCL-NGF/TF scaffolds was also demonstrated (Fig.…”
Section: In-vitro Growth Of Pc 12 Cells In Various Scaffoldsmentioning
confidence: 83%
See 4 more Smart Citations
“…The enhancement of PCL-NGF scaffolds of on the growth of PC12 cells in this study could be due to the interactions of NGF and Trk A receptors on the membrane of PC12 cells [16e18]. Furthermore, the rate of cellular uptake of RGD-modified polymeric micelles by PC12 cells was enhanced compared to that of micelles without modification [12,13]. Since TF has the same functions as RGD integrin, the promotion by TF on the growth of PC12 cells in PCL-NGF/TF scaffolds was also demonstrated (Fig.…”
Section: In-vitro Growth Of Pc 12 Cells In Various Scaffoldsmentioning
confidence: 83%
“…Tirofiban (TF) is a non-peptide RGD-mimetic molecule [10] that is produced from the snake venom, echistatin and has a function that is analogous to that of arginine-glycine-aspartic acid (RGD), a wellknown minimal cell-recognizable peptide of numerous adhesive plasma and extracellular proteins such as fibronectin [7,10,11]. Functionally, TF is extensively employed as a clinical anti-thrombosis drug to block the receptors of glycoprotein (GP) IIb/IIIa on the membrane of human platelets and thereby inhibit platelet aggregation [11,12]. The binding of ligands to integrins is well known to produce intracellular signals and regulate cellular growth and differentiation [12].…”
Section: Introductionmentioning
confidence: 99%
See 3 more Smart Citations